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Abstract Recent progress in genetic manipulation of
pigs designated for xenotransplantation ha6s shown
considerable promise on xenograft survival in primates.
However, genetic modification of multiple genes in
donor pigs by knock-out and knock-in technologies,
aiming to enhance immunological tolerance against
transplanted organs in the recipients, has not been
evaluated for health issues of donor pigs. We produced
transgenic Massachusetts General Hospital piglets by
knocking-out the a-1,3-galactosyltransferase (GT) gene
and by simultaneously knocking-in an expression
cassette containing five different human genes includ-
ing, DAF, CD39, TFPI, C1 inhibitor (C1-INH), and
TNFAIP3 (A20) [GT-(DAF/CD39/TFPI/C1-INH/TNFAIP3)/?]
that are connected by 2A peptide cleavage sequences to
release individual proteins from a single translational
product. All five individual protein products were
successfully produced as determined by western blot-
ting of umbilical cords from the newborn transgenic
pigs. Although gross observation and histological
examination revealed no significant pathological abnor-
mality in transgenic piglets, hematological examination
found that the transgenic piglets had abnormally low
numbers of platelets and WBCs, including neutrophils,
eosinophils, basophils, and lymphocytes. However,
transgenic piglets had similar numbers of RBC and
values of parameters related to RBC compared to the
control littermate piglets. These data suggest that
transgenic expression of those human genes in pigs
impaired hematopoiesis except for erythropoiesis. In
conclusion, our data suggest that transgenic expression
of up to five different genes can be efficiently achieved
andprovide the basis for determiningoptimal dosages of
transgene expression and combinations of the
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transgenes to warrant production of transgenic donor
pigs without health issues.
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Introduction
Xenotransplantation of organs from a readily available
animal species, such as the pig, into humans has been
considered as a potential solution to the critical
shortage of organs from deceased human donors for
transplantation (Yamada et al. 2005; Griesemer et al.
2009). However, the immune rejection response due to
species disparity between pigs and primates is the
major hurdle in successful xenograft transplantation.
A great amount of effort has been applied to prolong
survival periods of transplanted xenografts, including
the deletion of galactose-a-1,3-galactose antigens (a-
Gal) by knockout of the a-1,3-galactosyltransferase
(GT KO) gene (Lai 2002) and simultaneous inhibition
of human complement activation by the introduction
of human complement-regulatory genes, such as
CD46, CD55 (decay accelerating factor; DAF) (Lee
et al. 2011), and CD59, in the pigs used for
xenotransplantation (Lambrigts et al. 1998; McGregor
et al. 2004). The classical pathway complement-
regulatory protein C1 inhibitor (C1-INH) has also
been reported to be able to prevent complement-
mediated activation of xenogeneic endothelial cells
(Dalmasso and Platt 1993; Wheeler et al. 2012). Due
to the presence of non-Gal antibodies and molecular
incompatibilities between coagulation systems of
primates and pigs, thrombotic microangiopathy has
often developed in the vascularized graft tissues.
Moreover, inflammatory responses against pig organs
may evoke some acute vascular rejection. However,
these problems may be overcome by the introduction
of human coagulation-regulatory genes, such as
thrombomodulin and tissue factor pathway inhibitor
(TFPI) (Lee et al. 2011), or human anti-inflammatory
genes, such as hemeoxygenase-1 and CD39 (Wheeler
et al. 2012) and/or tumor necrosis factor-a induced
protein 3 (TNFAIP3; A20) (Daniel et al. 2004;
Oropeza et al. 2009), respectively. As a result,
significant progress has been made in that cardiac
xenograft from GT KO pigs with human complement
regulatory protein (hCD46, membrane cofactor pro-
tein) and human thrombomodulin molecules to
baboons had survived for over 900 days (Mohiuddin
et al. 2015). Also, an efficacy of renal xenotransplan-
tation has been established with survival and organ
functionality extending over 227 days with GT KO/
CD55 transgenic pig-to-macaque (Higginbotham et al.
2015).
Although the expression of these human genes in
the pigs for xeno-organ sources has revealed some
beneficial effects in the success of xenotransplanta-
tion, it is not clear and remains to be determined what
combination of genes would be better to develop a
state of immunological tolerance against transplanted
organs in the recipients. To achieve this goal, genetic
introduction of multiple genes into pigs would be
required. Thus, there has been an urgent need for the
development of an efficient strategy for the introduc-
tion of multiple human genes in those pigs.
In the present study, we attempted to produce a
transgenic piglet with GT KO and simultaneously
expressing multiple transgenes, including human DAF,
hCD39, hTFPI, hC1-INH, and hTNFAIP3. Here, we
report technical advantages of this approach to gener-
ate theMGHGT-(DAF/CD39/TFPI/C1-INH/TNFAIP3)/? piglets
as well as some health issues of these transgenic pigs.
Materials and methods
General information
All chemicals were purchased from Sigma-Aldrich
Corp. (St. Louis, MO, USA) and all restriction
enzymes were from New England Biolabs (Ipswich,
MA, USA) unless otherwise stated. The study protocol
and standard operating procedures for the treatments
of the pigs used in the present study were reviewed and
approved by the Institutional Animal Care and Use
Committee of the National Institute of Animal
Science, Rural Development Administration of Korea
(approval number: 2012-D-001, NIAS2015-671).
Construction of a zinc finger nuclease (ZFN)
vector
A pair of ZFN vectors was constructed for targeting
exon 9 of the GT gene. The coding sequence of DNA
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binding domain, used in the previous study (Hauschild
et al. 2011), was synthesized (Bioneer Inc., Daejeon,
Korea) and inserted into a ZFN expression vector,
pST1374, in the BamHI and XbaI sites to make a
PaGE9L/R vector. Cloned DNA sequences were
confirmed by DNA sequencing analysis (Genotech,
Daejeon, Korea).
Polymerase chain reaction and gene cloning
Total RNA was isolated from human umbilical vein
endothelial cells using TRIZOL reagent (Life Tech-
nologies, Carlsbad, CA, USA) and used for reverse
transcription by SuperScript III first-strand synthesis
system (Invitrogen, Life Technologies, Carlsbad, CA,
USA) according to the manufacturer’s instruction.
Complementary DNAs coding for human DAF,
CD39, TFPI, C1-INH, or TNFAIP3 were amplified
by PCR with pfu DNA polymerase (Enzynomics,
Daejeon, Korea) using specific primer sets (Suppl.
Table 1) and human cDNAs as the template. PCR
conditions were as follows: hDAF, initial denaturation
at 95 C for 5 min; 35 cycles of 94 C for 30 s, 65 C
for 30 s, and 72 C for 2 min; followed by a final
extension at 72 C for 5 min; hCD39, initial denatu-
ration at 95 C for 5 min; 35 cycles of 94 C for 30 s,
64 C for 30 s, and 72 C for 2 min; followed by a
final extension at 72 C for 5 min; hTFPI, initial
denaturation at 95 C for 5 min; 35 cycles of 94 C for
30 s, 62 C for 30 s, and 72 C for 1 min; followed by
a final extension at 72 C for 5 min; hC1-INH, initial
denaturation at 95 C for 5 min; 35 cycles of 94 C for
30 s, 64 C for 30 s, and 72 C for 2 min; followed by
a final extension at 72 C for 5 min; hTNFAIP3, initial
denaturation at 95 C for 5 min; 35 cycles of 94 C for
30 s, 64 C for 30 s, and 72 C for 3 min; followed by
a final extension at 72 C for 5 min. Amplified DNA
fragments were cloned into pGEM-easy TA cloning
vector (Promega, Madison, WI, USA), and all cloned
DNA fragments were confirmed by DNA sequencing
analysis (Genotech).
Construction of the pBS-2A5 vector
Multiple ‘self cleaving’ 2A peptide sequences (Hig-
ginbotham et al. 2015), including P2A, T2A, E2A, or
F2A, were synthesized (Bioneer Inc.) and then
inserted into the SacII and XhoI restriction enzyme
sites of the pBluescript II KS (Addgene, Cambridge,
MA, USA) plasmid to make a pBS-2A vector. Porcine
intercellular adhesion molecule 2 (ICAM2) promoter
sequences were amplified by PCR with pfu DNA
polymerase (Enzynomics) and a specific primer set
(Suppl. Table 1) using porcine genomic DNA as the
template. PCR was performed under the following
cycles: initial denaturation at 95 C for 5 min; 35
cycles of 94 C for 30 s, 66 C for 30 s, and 72 C for
1 min; followed by a final extension at 72 C for
5 min. The PCR product was inserted into pGEM-easy
TA cloning vector to make pTA-ICAM2. The pTA-
ICAM2 vector was then cut by XhoI and SalI, and the
digested DNA fragment was subcloned into the
corresponding sites of the pBS-2A vector. Next, five
human genes were digested with the following
restriction enzymes (DAF, EcoRV and AvrII; CD39,
SnaBI and SpeI; TFPI, SmaI and AvrII; C1-INH, StuI
and NheII, and hTNFAIP3, NruI and SalI, respec-
tively). The digested DNA fragments were subcloned
into pBS-2A vector to make a pBS-ICAM2-2A5
vector. Construction of the vector was confirmed by
digestion patterns with the following restriction
enzymes: XbaI, StuI, NheI, HindII, and BamHI. All
cloned DNA sequences were confirmed by DNA
sequencing analysis (Genotech).
Construction of the pLNDT-2A5-Gal expression
vector
Genomic DNA from the Massachusetts General
Hospital minipig (MGH minipig) was isolated using
a genomic DNA extraction kit (Qiagen, Valencia, CA,
USA) according to the manufacturer’s protocol. 1 kb
of 50 a-Gal and 1.1 kb of 30 a-Gal fragments were
amplified by PCR with pfu DNA polymerase (Enzy-
nomics) using specific primer sets (Suppl. Table 1)
and porcine genomic DNA as the template. The PCR
cycles were as follows: initial denaturation at 95 C
for 5 min; 35 cycles of 94 C for 30 s, 62 C for 30 s
and 72 C for 1 min; followed by a final extension at
72 C for 5 min. The PCR products were inserted into
a pGEM-easy TA cloning vector to make pTA-50 a-
Gal and pTA-30 a-Gal, respectively. The pTA-50 a-Gal
and pTA-30 a-Gal vectors were digested with NotI/
XhoI or SalI/AscI restriction enzymes, respectively,
and were subsequently inserted into the predigested
pLNDT vector, which contains neomycin as a positive
selection marker and diphtheria toxin A as a negative
selection marker, to make a a-Gal targeting vector,
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pLNDT-Gal. Finally, pBS-2A5 vector was digested
with XhoI and PacI restriction enzymes, and the
digested DNA fragment was subcloned into the
corresponding restriction sites of pLNDT-Gal to make
a pLNDT-2A5-Gal vector (Fig. 1a). All cloned DNA
sequences were confirmed by DNA sequencing anal-
ysis (Genotech).
Confirmation of expression of multiple human
genes in pig cell lines
Before establishment of cell lines, the constructed
ICAM2-2A5 vector was transfected into porcine
aortic endothelial cells (PAECs) to verify whether
the multiple human genes are expressed well in pig
cells. To confirm the expression of each transgene,
after the vector transfection, total RNA was isolated
using TRIZOL reagent, according to the manufac-
turer’s protocol, and was used for cDNA synthesis.
PCR was performed using a primer set for each
transgene (Suppl. Table 1) and cDNA as the tem-
plate. The PCR cycle was as follows: initial
denaturation at 95 C for 5 min; 22-36 cycles of
94 C for 30 s, the optimized annealing temperature
for 30 s, and 72 C for 30 s; followed by a final
extension at 72 C for 5 min.
Fig. 1 Construction of multiple gene expression vector and
identification of GGTA1 (GT) KO/multiple gene KI cell lines.
a Schematic of a ZFN-based KI process. The KI vector pLNDT-
2A5-Gal has an expression unit for multiple genes with 50 and 30
a-gal homology arms at its both end. In the bottom of this figure,
the structure of working pLNDT-2A5Gal vector is shown.
Primers used for identification of KI cell clones are shown above
and below the constructs. b Confirmation of the multiple genes
in porcine aortic endothelial cells (PAECs) by RT-PCR.
Established the ICAM2-2A5 vector which is the multiple gene
expression vector connected by 2A was transfected into PAECs
and verified expression of the multiple genes by 2A system
before establishment of cell lines. NC: normal PAECs; 2A5:
PAECs transfected ICAM2-2A5 vector. c Genotyping of
selected cell lines. Targeting vector was transfected into ear
fibroblasts from MGH minipigs (mpEF). Four cell lines were
established and confirmed by 3 of specific primer sets: 0.8 kb of
TG primer sets; 1 kb of 50 a-Gal primer sets; 1.1 kb of 30 a-gal
primer stets. Among the four cell lines, only two of them were
confirmed as transgenic cell lines. 1 normal pig genomic DNA;
#2 and 3 transgenic and Knock-in cells; #4 and 5 transgenic cell
lines
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Construction of knock-in cell line
Ear fibroblasts obtained from the MGH minipigs
(mpEF) were cultured in Dulbecco’s modified Eagle’s
medium (WelGene, Gyeongsan-si, Korea) containing
20 % fetal bovine serum, 1 mM of non-essential
amino acid (GIBCO), 1 mM of sodium pyruvate
(WelGene), 55 lM of b-mercaptoethanol (Life Tech-
nologies), and 1 % antibiotics (100 U/ml penicillin
and 100 lg/ml streptomycin; Life Technologies) at
37 C in an atmosphere of 5 % CO2. mpEF cells
(1 9 106 cells/ml) were co-transfected with 4 ug of a
pLNDT-2A5-Gal vector, which was linearized by a
NotI restriction enzyme and purified by phenol:chlo-
roform reagent, and 2 ug of a pair of ZFN vectors using
the Amaxa nuclofector system with U-023 program
(Lonza, Basel, Switzerland) and seeded into 48-well
plates. After 24 h, transfected cells were selected by
300 lg/ml of neomycin reagent (Invitrogen) for
9 days and each of the single colonies were cultured.
Genomic DNA was extracted from the candidate
mpEF transfectants using a DNeasy extraction kit
(Qiagen). PCR was performed using primer sets for
transgenes (TG), 50 a-Gal and/or 30 a-Gal (Suppl.
Table 2) and purified genomic DNAs as the template.
PCR cycles were as follows: initial denaturation at
95 C for 5 min; 30 cycles of 94 C for 30 s, 55 C
(for TG), 65 C (for 50 a-Gal) or 50 C (for 30 a-Gal)
for 30 s, and 72 C for 1 min; followed by a final
extension at 72 C for 5 min.
Production of reconstructed embryos and cloned
piglets
Porcine ovaries were obtained from a local slaughter-
house (Nonghyup Moguchon, Gimje, Korea). Cumu-
lus-oocyte complexes (COCs) were collected and
washed in Tyrode’s lactate-Hepes containing 0.1 %
(w/v) polyvinyl alcohol. Oocytes with several layers
of cumulus cells were selected and washed three times
in TCM-199 (GIBCO) supplemented with 0.1 %
polyvinyl alcohol (w/v), 3.05 mM D-glucose,
0.91 mM sodium pyruvate, 0.57 mM cysteine,
0.5 lg/ml luteinizing hormone, 0.5 lg/ml follicle
stimulating hormone, 10 ng/ml epidermal growth
factor, 10 % porcine follicular fluid (pFF), 75 lg/ml
penicillin G, and 50 lg/ml streptomycin (maturation
medium). For in vitro maturation, 50 COCs were
transferred into 500 lL of maturation medium in a
four-well dish (Nunc, Roskilde, Denmark). The
oocytes were matured for 40 h at 38.5 C under 5 %
CO2 in air. Somatic cell nuclear transfer was per-
formed as follows (Mezrich et al. 2003; Hauschild
et al. 2011). Briefly, matured oocytes in manipulation
medium supplemented with 5 lg/ml cytochalasin B
were enucleated by aspirating the first polar body,
metaphase II chromosomes, and a small amount of
surrounding cytoplasm. The freshly-thawed donor
cells treated with Roscovitine were inserted into the
perivitelline space. The karyoplast-cytoplast com-
plexes were placed into 0.2-mm diameter wire elec-
trodes (1 mm apart) of a fusion chamber covered with
0.3 M mannitol solution containing 0.1 mM MgSO4,
1.0 mMCaCl2 and 0.5 mMHepes. For reconstruction,
two DC pulses (1-s interval) of 1.5 kV/cm were
applied for 30 ls using an Electro-Cell fusion (Fuji-
hira Industry, Tokyo, Japan). Immediately after the
confirmation of fusion using a stereoscope, the recon-
structed embryos were transferred into both oviducts
of the surrogate on the same day or 1 day after the
onset of estrus. Pregnancy was diagnosed on day 28
after embryo transfer and was checked regularly every
week by ultrasound examination. The cloned piglets
with multiple transgenes were delivered by natural
parturition or Caesarean section.
Analysis of protein expression by western blotting
Total umbilical cord tissue extracts were harvested in
RIPA buffer and then centrifuged at 12,0009g for
10 min at 4 C. Total protein was quantified using the
BCA protein assay reagent, and then proteins were
separated by SDS-PAGE and transferred to a PVDF
membrane. After blocking in 5 % milk in Tris-
buffered saline containing Tween 20, the membrane
was incubated with the specific primary antibody
including human DAF (1:1000, #GTX103951, Gene-
Tex, Irvine, CA, USA), CD39 (1:1000, #HPA014067,
Sigma), TFPI (1:1000, #HPA005575, Sigma), C1-
INH (1:1000, #GTX105316, GeneTex), TNFAIP3
(1:1000, #ab92324, Abcam, Cambridge, MA, USA),
and b-actin (1:1000, #4967, Cell signaling, Danvers,
MA, USA), according to the manufacturer’s recom-
mendation. Signals were detected using ECL reagent
according to the manufacturer’s protocol. Densitom-
etry analysis of the blotted membrane was performed
using a LAS-3000 lumino image analyzer system
(Fujifilm, Tokyo, Japan).
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Necropsy and histopathological analysis
The MGH GT-(DAF/CD39/TFPI/C1-INH/TNFAIP3)/? piglets
had normal suckling behaviors and vital signs, and did
not show any birth defects after examination by
veterinarians. Immediately after the death about 48 h
after birth, the MGH transgenic piglets were necrop-
sied to collect tissues and organs such as the brain,
spleen, heart, liver, kidney, lung, stomach, testes,
thymus, tongue, aorta, and adrenal gland, etc. The
same tissues and organs were also collected from the
2-day-old non-transgenic littermates after being
humanly euthanized. For the anesthesia and eutha-
nization of control, it was injected with 20 mg/kg of
Zoletil 50 (Virbac, France) and 2.3 mg/kg of Rom-
pun (Bayer, Toronto, Canada). Tissue samples from
control and GT-(DAF/CD39/TFPI/C1-INH/TNFAIP3)/? pig-
lets were fixed in 10 % buffered formalin, embedded
in paraffin, and sectioned into 4-lm slices. Sec-
tions were stained with hematoxylin and eosin
(H&E) and subjected to histopathological analy-
sis. Blood was collected from the jugular vein of
GT-(DAF/CD39/TFPI/C1-INH/TNFAIP3)/? and control piglets
into tubes containing K2-EDTA (BD Vacutainer).
Blood from the cloned littermates, but not targeted, was
used as a control. Complete blood counting was
performed using a haematology analyser Cell-Dyn
3700 (Abbott Laboratories, Abbott Park, IL, USA) to
determine the level of white blood cells (WBC),
including the number of lymphocytes, monocytes,
neutrophils, eosinophils, and basophils, as well as, red
blood cells (RBC), platelets, haemoglobin, haematocrit,
mean corpuscular volume, mean corpuscular haemoglo-
bin concentration, and mean corpuscular haemoglobin.
Immunohistochemistry
Immunohistochemistry was carried out by the general
procedures for paraffin-embedded section on the slides
(Lee et al. 2006). For antigen retrieval, slides were
placed in citrate buffer and heated in a microwave
oven, then washed in dPBS. After treatment 0.3 %
Triton X-100 for 10 min, sections were blocked in two
steps; firstly, all sections were incubated with perox-
idase blocking solution (0.3 % H2O2 in methanol) to
block the endogenous peroxidase for 10 min, and next,
they were incubated with serum-free blocking solution
(#X0909, Dako, Denmark) for 1 h. The same primary
antibodies (dilution 1/100) that have been validated by
western blot analysis were incubated overnight. After
washing with 0.3 % Tween 20 in dPBS, the sections
were incubated with HRP-conjugated anti-rabbit sec-
ondary antibody for 1 h (1:200, #sc-2004, Santa Cruz,
USA). The human proteins in pig tissues were
visualized by using DAB (3,30-Diamino-benzidine,
#K3468, Dako) as a substrate for 5 min. Images of
DAB stained tissue sections were captured under a
light microscopy. Hematoxylin (#CS700, Dako) was
used for counter staining.
Statistical analysis
For statistical analysis, the GraphPad Prism 5.0
software package (GraphPad Software, La Jolla, CA,
USA) was used. Data were analyzed by equal
variance, two-tailed Student’s t test. p values\ 0.05
were considered statistically significant.
Results and discussions
Establishment of pig cells expressing multiple
human transgenes
During the first step to develop a transgenic piglet
expressing multiple human genes to minimize graft
rejection when transplanted in the primates, we
constructed a polycistronic vector to express the
following multiple human genes: hDAF, hCD39,
hTFPI, hC1-INH, and TNFAIP3, in this order. Based
on the findings that most acute vascular rejections are
characterized by endothelial cell activation and cellu-
lar damage resulting in thrombotic microangiopathy,
expression of human transgenes was constructed to be
specific in the endothelium of the organ source piglets
under the control of an ICAM2 promoter. Moreover,
to deplete the a-Gal antigen expression in the pig
fibroblast cells, 50 and 30 fragments of exon 9 of the GT
gene were added to both sides of the vector, respec-
tively, to induce a chromosomal knock-in (KI) of the
GT gene by homologous recombination (Fig. 1a). To
verify the expression of each transgene by the 2A
system, RT-PCR was performed with cDNA prepared
from porcine aortic endothelial cells (PAECs) tran-
siently transfected with ICAM2-2A5 as the template
and primers specific for each of the open reading
frames of human transgenes (Fig. 1b). We established
the KI transgenic fibroblast cell lines using the
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constructed vector. Established transgenic fibroblast
cell lines were confirmed by genomic PCR on the
junction region between 0.8 kb of promoter and
hDAF, and 1 kb of 50 and 1.1 kb of 30 exon 9 fragment
of the GT gene using specific primer sets, respectively
(Fig. 1c). The GT-(DAF/CD39/TFPI/C1-INH/TNFAIP3)/?
piglet cell lines were cultured and completely charac-
terized with the aforementioned methods and used in
somatic cell nuclear transfer to re-clone the clones.
Generation of transgenic piglets
Individual productivities of cloned piglets were
described in Table 1. The pregnancy (7/15 vs. 3/4)
and delivery (5/15 vs. 1/4) rates were comparable
between cloning and re-cloning donor cells, respec-
tively. Thirteen cloned piglets were born around days
114–117 of pregnancy by Caesarean section or
natural parturition (Table 2). Five (cloning ? re-
cloning) out of 13 cloned piglets were confirmed as
the GT-(DAF/CD39/TFPI/C1-INH/TNFAIP3)/? piglets by
genomic PCR with the above mentioned methods
(Fig. 2a, b). In addition, our data shows some techno-
logical improvement in the cloning efficiency using
MGH minipigs. The MGH minipig was established for
organ transplantation studies across the reproducible
homozygous major histocompatibility complex, called
the swine leukocyte antigen (Sachs et al. 1976).
Although reproductive characteristics of MGH minip-
igs are lower than those of domestic pigs (Conley et al.
1988; Mezrich et al. 2003) due to the inheritance of
homozygous major histocompatibility complex in the
highly inbred MGH minipigs, recipient-based cloning
efficiency (no. of newborn piglets/transferred cloned
embryos) of GT-(DAF/CD39/TFPI/C1-INH/TNFAIP3)/?
cloned MGH piglets was highly increased to 5.33 %
in the present study when compared to the value of
previous reports: 2.54 % in GT–MCP/? (Hwang et al.
2013) and 0.2 % in GT-/? cloned MGH minipigs
(Hauschild et al. 2011).
Histopathological and hematological investigation
Behavior and milk consumption of the MGH
GT-(DAF/CD39/TFPI/C1-INH/TNFAIP3)/? piglets were sim-
ilar to previously generated piglets (Ahn et al. 2011;
Kwon et al. 2011; Hwang et al. 2013). Gross
observation at necropsy shows no significant patho-
logical findings compared to non-transgenic litter-
mates. Histological examination of organs, including
the brain, spleen, heart, liver, kidney, lung, stomach,
testes, thymus, tongue, aorta, and adrenal gland, did
not show different pathological changes (data not
shown). However, a complete blood count test of the
MGH transgenic piglets showed significantly lower
blood cell counts for WBCs (p = 0.001), including
neutrophils (p = 0.035), lymphocytes (p = 0.008),
eosinophils (p = 0.019), and basophils (p = 0.005),
while no significant changes were observed in mono-
cyte counts than those of non-transgenic littermates.
Platelet counts (p = 0.008) were also significantly
decreased in the transgenic piglets. On the other hand,
RBC counts, hemoglobin, hematocrit, and mean
corpuscular volume were not significantly changed,
although a significant decrease in mean corpuscular
hemoglobin (p = 0.017) was observed in the trans-
genic piglets (Table 3). These data suggest that
transgenic expression of those human genes in pigs
impairs hematopoiesis, but does not or minimally
affects erythropoiesis.
Targeted transgenic protein expression was con-
firmed by western blot analysis using the umbilical
cord of the GT-(DAF/CD39/TFPI/C1-INH/TNFAIP3)/? piglets
(Fig. 2c). In addition, the protein expressions were
Table 1 Pregnancy and delivery rate by donor cell types
Types No. of embryos transferred No. of surrogates
Transferred Pregnanta Deliveredb
Cloning 122 ± 29 15 7 5
RE-cloning 123 ± 29 4 3 1
Data were expressed as mean ± standard deviation. Cloning: primary TG cell; RE-cloning: TG cells originated from cloning pig
a Pregnancy was confirmed by gestation sac formation using ultrasound examination at 28 days after embryo transfer
b No. of surrogates delivered/No. of surrogates pregnant
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analyzed by immunohistochemical analysis. The
hCD39, hTFPI, and hTNFAIP3 proteins were obvi-
ously detected in kidney, liver and aorta of the piglets,
but not in those of the control wild-type piglet
(Fig. S1). However, unlike western blot analysis,
some of the tansgenic proteins, such as hDAF and
hC1-INH, were not or weakly detected in those
tissues, possibly due to low affinities of the antibodies
on the tissue sections. Because all five human proteins
were designed to be expressed as a single gene product
Table 2 Full-term development of multi-transgenic cloned piglets
Types No. of surrogates Delivery statusa No. of piglets born Targeting
Total Survival Deadb
Cloning 1 117 (C-sec) 4 2 2 1
2 117 (C-sec) 1 1 –
3 116 (natural) 5 5 2
4 117 (C-sec) 1 1 –
5 114 (C-sec) 1 1 1
Re-cloning 6 114 (C-sec) 1 1 1
Cloning: primary TG cell; Re-cloning: TG cells originated from cloning pig
All five targeted piglets died about 48 h after birth without specific symptoms
a Pregnancy periods after transfer of multi-transgenic cloned embryos
b Piglets that died within 1 day
Fig. 2 Development of multiple gene expression pigs with GT
knock-out. a The newborn GT-(DAF/CD39/TFPI/C1-INH/TNFAIP3)/?
Massachusetts General Hospital (MGH) piglet delivered by
Caesarean section. b Genotyping of the piglets by RT-PCR.
Three of the multiple transgenic piglets were confirmed
genetically with the three primer sets. PC positive control
which is genomic DNA from cell line #2; NC negative control
which is normal pig genomic DNA; 1, 2 and 3: genomic DNA
from Knock-in pig #1, 2, and 3. c western blot analysis. The
knock-in piglets expressed the multiple human genes like the
constructed vector. NC negative control which is a normal pig;
TG a newborn GT-(DAF/CD39/TFPI/C1-INH/TNFAIP3)/? Mas-
sachusetts General Hospital (MGH) piglet. Red boxes represent
the exact protein sizes
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and subsequent western blot analysis of piglet tissues
has confirmed that individual proteins are successfully
produced by precise cleavage at the ‘self-cleaving’ 2A
peptide sequences, hDAF and hC1-INH proteins are
certainly expressed in the transgenic piglets. This
approach is practically advantageous in the transgenic
expression of more than one protein from a single
vector than the conventional approach, which requires
the use of internal ribosome entry sequences or
additional promoters, often leading to the differential
expression level of proteins.
There have been previous reports demonstrating
that transgenic expression of human DAF, CD39,
TFPI, or TNFAI3 genes except C1-INH, alone or in
combination, in pigs show no significant pathology in
blood cells, such as leucopenia and thrombocytopenia.
Moreover, the expression of C1-INH protein appears
not to be directly correlated with leucopenia and
thrombocytopenia because it plays a protective role
against complement-mediated activation and subse-
quent cellular damages in endothelial cells (Dalmasso
and Platt 1993; Fiane et al. 1999). In the current
studies, the ectopic expression of all five transgenes in
piglets, however, resulted in leucopenia and throm-
bocytopenia. Because blood leukocytes are the first
line of defense against infection, and platelets play
crucial roles to stop bleeding after blood vessel
injuries, leucopenia and thrombocytopenia may be a
major cause of the death of the transgenic piglets.
Among five transgenes, TFPI has been reported to
promote platelet aggregation, leading to a remarkable
decrease in platelet count (Nishioka et al. 2002; Ellery
et al. 2015), which could partially explain the low
platelet count in our transgenic piglets. Additional
contributors to the decreased platelets in the pigs
might be CD39 and DAF overexpression since
transgenic production of human CD39 and DAF in
mice resulted in slow clotting of human blood (Dwyer
et al. 2006; Miwa et al. 2010).
Among the five target proteins that are consistently
expressed in endothelial cells of the transgenic piglets,
secretory proteins (TFP1 and C1-INH) that are circulat-
ing in the blood may systemically affect development of
immune cells. Another possible explanation could be
based on the finding that the human ICM2 promoter
drove expression of transgene in endothelial cells and
leukocytes, includingneutrophils andmonocytes (Cowan
et al. 1996, 2003). Similar to the human promoter
activities in the aforementioned transgenic mice, it is
possible that the porcine ICAM2 promoter might be
active in endothelial cells and leukocytes, but not in
erythrocytes, consequently driving production of the five
target proteins in both endothelial cells and leukocytes
and affecting hematopoiesis in the transgenic piglets.
Table 3 Mean values of hematological parameters in the newborn cloned piglets
Abbreviation Units Referencea Multi-TG (n = 2) Controlb (n = 2)
WBC (p = 0.001) 9103/ll 16.8–32.4 1.3 ± 0.66 13.6 ± 0.35
Neutrophils (p = 0.035) 9103/ll 7.6–24.6 0.14 ± 0.01 3.77 ± 1.44
Lymphocytes (p = 0.008) 9103/ll 3.42–12.7 0.53 ± 0.41 7.65 ± 1.21
Monocytes 9103/ll 0.2–3.2 0.58 ± 0.25 1.27 ± 0.34
Eosinophils (p = 0.019) 9103/ll 0.0–0.7 0.03 ± 0 0.67 ± 0.18
Basophils (p = 0.005) 9103/ll 0.0–0.5 0.03 ± 0.004 0.16 ± 0.02
Platelet (p = 0.008) 9103/ll 200–800 74.9 ± 27.9 232 ± 2.8
RBC 9103/ll 6.4–9.3 5.98 ± 2.59 7.38 ± 1.1
Hemoglobin g/dl 11.4–13.5 10.19 ± 4.4 13.7 ± 2.47
Hematocrit % 35–41 34.95 ± 15.5 40.3 ± 6.2
Mean corpuscular volume fl 48.1–63.9 58.35 ± 0.64 54.7 ± 0.35
Mean corpuscular hemoglobin pg 13.7–18.8 17.0 ± 0 18.5 ± 0.7
Mean corpuscular hemoglobin concentration %/g/dl 30.8–36 29.2 ± 0.28 33.9 ± 0.84
Two-tailed Student’s t test (p\ 0.05)
a Laboratory Animal Medicine 2nd edition, Edited by: Fox et al., Chapter 15—Biology and Diseases of Swine
b Control: non-transgenic cloned littermates
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Very recently, an abstract was reported that the
survival of renal xenograft from a donor transgenic pig
with 6 transgenes (GT KO/CD46/DAF/EPCR/TBM/
CD39) to baboon survived for 135 days (Ayares et al.
2015). The survival period of the 6-gene TG pig was
shorter than the GT KO/CD55 transgenic pig
([227 days). It is difficult to compare the survival
results only in the survival period because of many
different circumstances in both groups. Kidneys from
GT KO/CD55/CD59/HTF pigs were transplanted into
four baboons, and all of them were rejected within
10 days (Hawthorne et al. 2015).
Although organs from GT KO pigs with transgenic
expression of multiple human genes involved in the
immune and coagulation systems has resulted in an
extended xenograft survival in primates (Le Bas-
Bernardet et al. 2011; Ayares et al. 2015; Hawthorne
et al. 2015), much remains to be improved in
generating multiple transgene expression in pigs for
xenograft survivals, as the survival of xenografts is
highly dependent upon many factors, including the
kinds of transgenic genes, expression levels, and
recipient and organ types.
Our current studies confront health issues of donor
pigs with genetic modification of multiple genes that
could bring beneficial aspects associated with immune
suppression and anti-clotting of blood. Further studies
are needed in both appropriate genetic modifications
and immune responses in order to further extend
survival.
Conclusions
In the present communication, we produced the
transgenic piglets capable of simultaneously express-
ing five different human genes without a-Gal antigen
expression [GT-(DAF/CD39/TFPI/C1-INH/TNFAIP3)/?].
Accordingly, full understanding of the molecular
mechanism involved in xenograft rejection, as well
as the development of efficient technology to produce
genetically manipulated organ-source piglets that
harbor multiple human genes, are essentially required
to improve the success rates of xenotransplantation in
the future. However, several issues still remain to be
resolved for clinical application of these strategies,
including the selection of transgenes and poten-
tial pathological issues, such as leucopenia and
thrombocytopenia, presented in this study. Better
understanding of the biology and functional roles of
candidate transgenes may help to develop safe and
efficient approaches for the genetic manipulation of
multi-TG pigs and for the successful xenotransplan-
tation in the future.
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